Structure Characterization and Action Mechanism of an Antiaging New Compound from <i>Gastrodia elata</i> Blume

Farooq, Umer; Pan, Yanjun; Lin, Yanfei; Wang, Ying; Osada, Hiroyuki; Xiang, Lan; Qi, Jianhua

doi:https://doi.org/10.1155/2019/5459862

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Methods Results Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Special Issue

Chemistry, Biology, and Pharmacology of Modulators of Oxidative Stress

View this Special Issue

Research Article | Open Access

Volume 2019 | Article ID 5459862 | https://doi.org/10.1155/2019/5459862

Structure Characterization and Action Mechanism of an Antiaging New Compound from Gastrodia elata Blume

Umer Farooq,¹Yanjun Pan,¹Yanfei Lin,¹Ying Wang,¹Hiroyuki Osada,²Lan Xiang,¹and Jianhua Qi¹

Academic Editor: Luciano Saso

Received25 Jan 2019

Revised23 Mar 2019

Accepted16 Apr 2019

Published06 May 2019

Abstract

A new compound, bis(4-hydroxybenzyl)ether mono-β-L-galactopyranoside (1), was isolated from the rhizome of Gastrodia elata Blume. Its structure was elucidated using extensive spectroscopic analysis, including 1D and 2D NMR, HR-ESI-TOF-MS, and chemical derivatization. Compound 1 extended the replicative lifespan of K6001 and the chronological lifespan of YOM36 yeast strains. To understand the mechanism of action, oxidative stress assessment, reactive oxygen species (ROS) and malondialdehyde (MDA) levels, catalase (CAT) and total glutathione peroxidase (GPx) activity assays, and replicative lifespan assay of sod1, sod2, uth1, and skn7 yeast mutant strains were performed. Results indicated the significant increase in the survival rate of yeast under oxidative stress after treatment with 1. ROS and MDA levels were reduced significantly. Meanwhile, the activity of CAT and GPx was significantly increased. The lifespan of sod1, sod2, uth1, and skn7 mutants of K6001 was not affected by 1. Furthermore, we investigated the gene expression related to longevity after administrating 1. The significant increase of Sir2 and reduction of Uth1 gene expression in the 1-treated group were observed. These results indicated that antioxidative stress played an important role in the antiaging effect of 1; Sir2 and Uth1 genes were involved in antiaging effects of 1.

1. Introduction

Aging is natural process characterized by deterioration in cellular functions, leading to a progressive decline in physiological function. This deterioration is considered as a major risk factor for many human degenerative diseases, including cancer, cardiovascular disorders, diabetes, Alzheimer’s disease, and Parkinson’s disease [1]. In the recent years, various research efforts have been made to slow aging and counter age-related diseases to extend human life and health span [2]. Several antiaging drugs such as metformin and rapamycin are commercially available, but these drugs are not specific [3]. These drugs can relieve the clinical symptoms but cannot cure the age-related diseases. Thus, the identification and development of new antiaging drugs with improved characteristics is one of the most important goals for researchers [4].

Oxidative stress is an important factor contributing to the aging process. It results from imbalance between reactive oxygen species (ROS) production and antioxidant defense. ROS are produced in the energy metabolism of mitochondria. Normally, a certain amount of ROS is essential for biological function. Excess ROS can be utilized by endogenous antioxidant such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and other enzymes. The overproduction of ROS is related to oxidative stress and can cause damage to biological molecules [5, 6]. Various literatures reported that natural or synthetic antioxidants can be used to counter harmful effects of oxidative stress [7, 8]. Therefore, developing a drug which increases the antioxidative potential and maintains the endogenous defense and repair mechanisms may improve health expectancy, enhance longevity, and contribute to treat age-related disorders.

The budding yeast Saccharomyces cerevisiae is one of the aging models for the basic mechanism of aging. Both replicative and chronological lifespans of yeast are useful assay systems for aging evaluation. The replicative lifespan of yeast represents the number of daughter cells produced by one single mother cell. The chronological lifespan is delimited as the time when one yeast cell can survive in the nondividing G0 state [9, 10]. In our previous studies, we have utilized the replicative lifespan assay of K6001 to screen many antiaging compounds from food and traditional Chinese medicines such as cucurbitane glycosides, ganodermasides A–D, and parishin. Furthermore, we have done the action mechanism analysis of these compounds at cell level [11–13]. In spite of that, the replicative lifespan of K6001 has many merits like low cost, short generation time, and more easy operating [14]. The result accuracy of lifespan assay is possibly affected by artificial cause. Therefore, the chronological lifespan of YOM36 yeast is used to confirm antiaging effects of screened compounds in the present study.

Gastrodia elata is a popular traditional Chinese medicine. Conventionally, G. elata is used in the treatment of epilepsy, vertigo, headache, insomnia, hypertension, and dementia due to its anticonvulsant, analgesic, calming, hypnotic, nootropic, and antibrain aging properties [15]. G. elata has many active compounds like gastrodin, gastrol, parishin, vanillin, vanillyl alcohol, 4-hydroxybenzaldehyde, and 4-hydroxybenzoic acid [15–18]. These compounds exhibit anti-inflammatory, antiasthmatic, neuroprotective, and antioxidant activities [17–20]. Gastrodin, a major constituent of G. elata, has been developed to a commercially available drug for neurasthenia-induced headache [21]. Previously, we found that antioxidative stress involved in antiaging effect of parishin [13]. In the present study, we isolated a new antiaging constituent from G. elata under guidance of K6001 yeast lifespan assay and the chronological lifespan assay of YOM36 yeast. Here, we report isolation, structure elucidation, biological activity, and mechanism action of a new compound bis(4-hydroxybenzyl)ether mono-β-L-galactopyranoside (1) (Figure 1) from G. elata.

2. Material and Methods

2.1. General

Preparative HPLC analysis was performed using the HPLC system equipped with Elite P-230 pumps. The Agilent Technologies 6224A Accurate-Mass TOF LC/MS system was used to measure the mass spectra. For recording the NMR spectra, the Bruker AV III-500 spectrometer was used. NMR chemical shifts in δ (ppm) were referenced to solvent peaks of δ_C 49.0 and δ_H 3.30 for CD₃OD. Silica gel (Qingdao Haiyang Chemical Co. Ltd., Qingdao, China) and octadecylsilane (Cosmosil 75 C18-OPN, Nacalai Tesque, Japan) were used for column chromatography. For TLC analysis, precoated silica gel (0.25 mm) and RP-18 plates (0.25 mm) were used. A JASCO P-1030 digital polarimeter was used to measure the optical rotations of the isolated compound.

2.2. Plant Material

The dried rhizome of G. elata Blume was purchased from Chengdu, Sichuan, China, and identified by Prof. Jianhua Qi from the College of Pharmaceutical Sciences, Zhejiang University. A voucher specimen (20110521) was deposited at the Institute of Materia Medica, Zhejiang University.

2.3. Extraction and Isolation

Dried plant material (1.2 kg) was crushed and extracted twice with 80% aqueous methanol. The extract was filtered and concentrated in vacuum to obtain a crude extract (121 g). The crude extract was further dissolved in water and partitioned between ethyl acetate and water. The water layer was concentrated to obtain 110 g of a dried sample, which was separated by ODS open column and eluted with MeOH/H₂O (15 : 85, 20 : 80, 25 : 75, 30 : 70, 35 : 65, 40 : 60, 70 : 30, and 100:0) to obtain eight fractions. The active sample (1.8 g), eluted with MeOH/H₂O (35 : 65 and 30 : 70), was chromatographed on a silica gel open column and eluted with CH₂Cl₂/MeOH (10 : 0, 9 : 1, 8 : 2, 6 : 4, 5 : 5, 4 : 6, 3 : 7, 2 : 8, and 0 : 10) to obtain eight fractions. The active fraction (90 mg), eluted with CH₂Cl₂/MeOH (8 : 2), was further purified through ODS open column and successively eluted with MeOH/H₂O (20 : 80, 25 : 75, 30 : 70, 35 : 65, and 100 : 0) to obtain seven fractions. The active fraction (9.5 mg), eluted with MeOH/H₂O (20 : 80), was subjected to HPLC purification (Cosmosil 5C18-MS-II (), flow rate: 3 mL/min, 20% aq. MeOH) to obtain an active sample. This active sample was again purified through a second HPLC purification (Cosmosil 5C18-MS-II (), flow rate: 3 mL/min, 15% aq. MeCN) to yield a pure compound (1.6 mg, ) as the active substance.

2.4. Acid Hydrolysis of 1 and Sugar Analysis

The absolute configuration of the sugar moiety of 1 was determined according to the literatures [22, 23]. The compound (200 μg) was dissolved in 300 μL MeOH and then hydrolysed at 80°C for 4 h in 2 M HCl. The reaction solution was concentrated to dryness and then partitioned between chloroform and water. The water layer was concentrated in vacuum and redissolved in pyridine (100 μL) containing 5 mg/mL L-cysteine methyl ester. The reaction was heated at 60°C for 60 min. Subsequently, 100 μL of o-tolylisothiocyanate (5 mg/mL) in pyridine was added to the mixtures, which were then further heated at 60°C for 60 min to obtain an aldose o-tolylthiocarbamate derivative. The aldose thiocarbamate standards were synthesised as follows: L-galactose and D-galactose were derivatized with L-cysteine methyl ester and o-tolylisothiocyanate according to the procedure reported in literature. The reaction mixture was dried, redissolved in methanol, and directly analyzed with the Agilent Technologies 6224A Accurate-Mass LC-TOF-MS under the following conditions: Agilent Extend C18 column (3.5 μm, ), detected at 210 nm, MeOH/H₂O/formic acid (30 : 70 : 0.1) and MeOH/H₂O/formic acid (95 : 5 : 0.1), and flow rate: 0.45 mL/min.

L-Galactose was identified as the sugar moiety of 1 by comparing the retention time of its aldose thiocarbamate derivative () with those of aldose thiocarbamate standards: L-cysteine-L-galactose () and L-cysteine-D-galactose ().

2.5. Yeast Strains, Culture Media, and Lifespan Assay

The yeast strains, wild-type BY4741, K6001 with a W303 background and sod1, sod2, uth1, and skn7 mutants, and YOM36 were used. In our study, we utilized the characteristic of K6001 that mother cells can live in galactose and glucose medium but daughter cells will die in glucose medium to do replicative lifespan assay. The lifespan assay and media for yeast strain were similar to those described in the previous literature [12]. To find the optimal dose of 1 for yeast, we performed a dose-dependent experiment. Briefly, K6001 cells were inoculated in 5 mL of yeast-peptone-galactose medium and cultured at 180 rpm in a shaker at 28°C for 24 h. Approximately 1 mL of yeast culture broth was centrifuged at 1,500 rpm for 3 min to produce yeast pellets. These yeast pellets were washed thrice and diluted with PBS solution. After that, approximately 4,000 yeast cells counted with a hemocytometer were evenly smeared and kept as single cell on glucose agar plates containing different sample concentrations. The plates were incubated for two days at 28°C, and the dead daughter cells produced by mother cells were calculated under a microscope. To get the accurate results, we randomly selected forty mother cells and did analysis. Each experiment was repeated thrice. The bioassay method used for the replicative lifespan of sod1, sod2, uth1, and skn7 mutants was the same as that for K6001 yeast, and the optimal concentration of 1 for the replicative lifespan of K6001 was used.

The chronological lifespan assay was performed as described in another report [24]. Briefly, YOM36 yeast cells stored in -30°C were cultured in synthetic defined (SD) medium for 24 h and then inoculated 0.01 OD yeast into SD medium containing 0, 1, or 3 μM of 1. Yeasts were grown in a shaker at 180 rpm and 30°C. Growth kinetics was recorded by measuring the OD600 value every 2 or 4 h until the stationary phase was reached. After that, the colony-forming units (CFUs) of each group every 2 days was measured and the CFUs on day 3 was denoted as 100% survival. The survival rate was calculated via counting colony-forming units (CFUs) every 2 days.

2.6. Antioxidative Stress Assay

To get the optimal concentrations of H₂O₂, we first used different concentrations of H₂O₂ at 3, 5, 6, 9, and 10 mM to do preliminary experiments. The 9 mM H₂O₂ was determined as the optimal concentrations and used to do antioxidative stress assay. Wild-type BY4741 yeast was inoculated in 5 mL of yeast-peptone-D-glucose (YPD) medium and cultured at 160 rpm in a shaker at 28°C for 24 h. The yeast cells were processed with 25 mL of YPD medium at 0.1 OD600 and cultured with a 0, 1, 3, or 10 μM compound and 10 μM resveratrol. Then, 5 μL of culture broth with equal number of cells in each group was dropped onto glucose agar plates containing 9 mM H₂O₂ and cultured at 28°C for 4 days. Yeast growth on the plates was observed and photographed. Resveratrol (Res) was used as a positive control.

To accurately measure the antioxidative abilities of the compound, another experiment was performed to examine the antioxidative stress of the compound. At first, we also investigated the microcolony status formed on agar plates which contained different concentrations of H₂O₂ at 0, 1, 3, 5, and 7 mM. Because 5 mM H₂O₂ can reduce 50%-60% microcolonies formed on the agar plate, we used this concentration to do the experiment. BY4741 yeast was incubated for 24 h after treatment with a 0, 1, 3, and 10 μM compound or 10 μM resveratrol. Subsequently, approximately 200 yeast cells treated with the compound at various concentrations were spread onto the glucose medium agar plates with 0 or 5 mM H₂O₂. The plates were incubated at 28°C for 3 days, and the number of colonies in each agar plate was counted. Survival rate was calculated as the number of colonies in agar plates with 5 mM H₂O₂ divided by that without H₂O₂.

2.7. ROS and MDA Assays

ROS assay was performed by adopting the same method as described in the previous study [13]. BY4741 yeast cells were cultured at 28°C in a shaker incubator with the compound (0, 1, 3, and 10 μM) for 23 h. Then, DCFH-DA was added to 1 mL of cells to obtain a final concentration of 40 μM, and the cells were incubated in a shaker at 28°C for 1 h in the dark. The cells were then washed thrice with PBS, and a fluorescence plate reader was used to detect DCF fluorescence intensity of cells by using 488 and 525 nm of excitation and emission wavelengths, respectively.

MDA assay was performed using the method reported in the literature [13]. BY4741 yeast cells were incubated with the compound (0, 1, 3, and 10 μM) for 24 h. Yeast cells were washed thrice with PBS. After washing, the cells were resuspended in 1 mL of PBS and ultrasonicated for 5 times, followed by freezing (5 min in liquid nitrogen), thawing (2 min in water bath at 37°C), and sonicating for 5 min. Then, the cell lysates were centrifuged at 4°C for 15 min at 12,000 rpm, and the supernatant was obtained to measure the MDA level by using the MDA assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China).

2.8. Catalase and Total Glutathione Peroxidase Assay

At first, BY4741 yeast cells were treated with (1) or Res in liquid glucose medium for 24 h at 28°C. Then, yeast cells were collected and sonicated for five minutes. The cell lysates were centrifuged, and the supernatant was removed for catalase and glutathione peroxidase assays, respectively. The enzyme activities of the supernatant were tested using catalase and total glutathione peroxidase assay kits (Beyotime Biotechnology Limited Company, Shanghai, China) following the manufacturer’s instructions, respectively.

2.9. Real-Time Polymerase Chain Reaction Analysis

Wild-type BY4741 was incubated with the negative control or 1 and 3 μM 1 in glucose medium overnight. RNA was extracted from yeast cells in the exponential phase through the hot-phenol method. The reverse transcription was performed using the HiFi-MMLV cDNA Kit (Cowin Biotech, Beijing, China) and 5 μg of RNA. Real-time polymerase chain reaction (RT-PCR) was performed in reference to the previous study [13] by using CFX96 Touch (Bio-Rad, Hercules, USA) and SYBR Premix EX Taq (Takara, Otsu, Japan). Thermal cycling parameters were as follows: 40 cycles, 94°C for 15 s, 55.4°C for 15 s, and 68°C for 20 s. Primers used were as follows: for Uth1, sense 5-CGC CTC TTC TTC CTC CTC TT-3 and antisense 5-ACC ATC GGA AGG TTG TTC AG-3; for Sir2, sense 5-CGT TCC CCA AGT CCT GAT TA-3 and antisense 5-CCA CAT TTT TGG GCT ACC AT-3; for TORC1, sense 5-TTG GTA CAA GGC ATG GCA TA-3 and antisense 5-TAC CGT CAA TCC GCA CAT TA-3; and for TUB1, sense 5-CCA AGG GCT ATT TAC GTG GA-3 and antisense 5-GGT GTA ATG GCC TCT TGC AT-3. Relative gene expression data was analyzed using the 2^-ΔΔCt method. The amounts of Uth1, Sir2, and TORC1 mRNA were normalized to that of TUB1.

2.10. Statistical Analysis

Significant differences among groups in all experiments were determined by one-way ANOVA, followed by two-tailed multiple -tests with Bonferroni correction by using the SPSS biostatistics software. A value less than 0.05 was considered statistically significant.

3. Results

3.1. Isolation

The MeOH extract of G. elata was partitioned between ethyl acetate and water. The active water layer was chromatographed on a series of ODS and silica gel open column under the guidance of the K6001 replicative lifespan bioassay system to obtain the active fraction. This active fraction was purified by HPLC twice to yield a pure active compound.

3.2. Structure Elucidation

The HR ESI-TOF mass spectrum revealed an accurate mass molecular ion (M+NH₄)⁺ at m/z 410.1813 consistent with the molecular formula C₂₀H₂₄O₈. The ¹H NMR data (Table 1) indicated the presence of eight aromatic protons, which are due to two para-substituted benzene (6.72 (2H, d, ), 7.08 (2H, d, ), 7.14 (2H, d), and 7.26 (2H, d, )) and two benzylic methylene linked to one oxygen (4.45 (2H, s) and 4.54 (2H, s)). Several multiple peaks at δ_H 3.36–3.85 and an anomeric proton (4.88 (1H, d, )) indicated the existence of sugar moiety. The ¹³C NMR data (Table 1) of the compound revealed the presence of two benzene rings (δ_C 116.0, 117.7, 129.4, 130.3, 130.7, 136.6, 158.2, and 158.4) and one sugar moiety (δ_C 102.3).

The ¹H-¹H COSY data showed the following correlation signals: H-2 and H-3, H-5 and H-6, H-2 and H-3, H-5 and H-6, H-1 and H-2, H-2 and H-3, H-3 and H-4, H-4 and H-5, and H-5 and H-6. Based on these signals, a structural fragment of the compound was obtained as shown in Figure 2. In addition, HMBC data showed the following major ¹H-¹³C correlation: H-2 to C-7, H-3 to C-4, H-5 to C-4, H-6 to C-7, H-7 to C-1, C-2, and C-6, H-2 to C-7, H-3 to C-4, H-5 to C-4, H-6 to C-7, H-7 to C-1, C-2, and C-6, and H-1 to C-4. The anomeric proton H-1 of the sugar moiety to C-4 in the HMBC indicated the location of the sugar moiety (Figure 2). According to the above signals, the structure fragments were connected to obtain the planar structure of 1 as shown in Figure 2.

The absolute configuration and type of sugar moiety were confirmed by the degradation of 1 and by the comparison of aldose thiocarbamate derivative of the compound with aldose thiocarbamate derivatized standards. Thus, L-galactose was identified as the sugar moiety of the compound. The β configuration of L-galactose was determined from the coupling constant of the anomeric protons (δ_H 4.88).

Based on the above-mentioned spectral data, the chemical structure of 1 was elucidated as bis(4-hydroxybenzyl)ether mono-β-L-galactopyranoside, as shown in Figure 1.

3.3. Antiaging Effect of 1

To screen the antiaging potential of samples, K6001 yeast replicative lifespan bioassay was used, because of its shorter lifespan and better reproducibility than other typically used antiaging models [14]. In our previous studies, we used this bioassay system to screen various antiaging compounds [11–13]. Resveratrol was used as a positive control to check the reliability of the bioassay system. Resveratrol exhibited antiaging potential in various organisms. In our previous study, the most effective concentration of resveratrol was 10 μM in yeast replicative lifespan bioassay system [12]. In this study, the antiaging potential of 1 at 0.1, 1, 3, and 10 μM was evaluated using K6001 replicative lifespan assay. Figure 3(a) shows that 1 significantly extended the replicative lifespan of yeast compared with the negative control group at 1, 3, and 10 μM ( and ). Furthermore, we confirmed the antiaging effect of 1 with the chronological lifespan of YOM36 yeast. The chronological lifespan of YOM36 in the 1-treated group was dose-dependently increased after treatment with 1 at doses of 1 and 3 μM (Figure 3(b)). These results suggested that 1 had an antiaging potential.

(a)

(b)

Figure 3

Effect of 1 on the replicative lifespan of K6001 (a) and the chronological lifespan of YOM36 (b) yeast strains. The average lifespan of K6001 was as follows: control, ; Res at 10 μM, ; and 1 at 0.1 μM, ; at 1 μM, ; at 3 μM, ; and at 10 μM, . Each experiment was repeated thrice, and the results were expressed as . and indicate a significant difference relative to the control ( and ). The days at which viability is equal to 0 of YOM36 after treatment with 1 were as follows: control, 11 days; 1 at 1 μM, 11 days; and 1 at 3 μM, 17 days.

3.4. 1 Improves the Survival Rate of Yeast under Oxidative Stress Conditions

Oxidative stress is one of the major contributing factors of aging and age-related pathologies. Oxidative stress produced by oxidant by-products or free radicals can cause extensive damage to DNA, protein, and lipid [25]. Therefore, it is essential to evaluate the antioxidant potential of 1. Results in Figure 4(a) indicated that treatment with 1, 3, and 10 μM of 1 significantly improved the survival of yeast under oxidative stress induced by 9 mM H₂O₂. In another experiment, we used agar plates to measure the viability of yeast under oxidative stress induced by 5 mM H₂O₂. As shown in Figure 4(b), the survival rate of yeast after treatment with 1 at 1, 3, and 10 μM significantly increased compared with the negative control group under oxidative stress (). Moreover, the survival rate of yeast in the 1 group at 3 μM was higher than that of the Res group (). The survival rate of yeast between 3 μM and 10 μM groups of 1 has no significant difference. These results indicated that antioxidant potential played an important role in the antiaging effect of 1, and the antioxidative stress ability of 1 is stronger than that of Res.

(a)

(b)

Figure 4

Effects of 1 on the oxidative resistance of yeast. (a) BY4741 yeast with the control and 1-treated group were dropped in the same YPGlucose agar plate mixed with 9 mM H₂O₂. After 4 days, the growth of yeast cells in different groups was photographed. (b) Effect of 1 on the survival rates of yeast under oxidative stress condition when treated with 1, 3, and 10 μM of 1 or 10 μM of Res. Each experiment was performed at least thrice. indicates a significant difference between control and other groups (). ## represents a significant difference between Res and 3 μM group of 1 (). ++ represents a significant difference between 1 and 3 μM groups of 1 (). ns indicates no significant difference.

3.5. Effects of 1 on the ROS and MDA Levels, CAT and GPx activity of Yeast

Increased production of ROS can cause further mitochondrial deterioration and global cellular damage, which support the role of ROS in aging [26]. We measured the ROS level of yeast after treatment with 1 at 24 h interval. Figure 5(a) shows that the ROS levels in yeast at 24 h decreased significantly after treatment with 1 at 1, 3, and 10 μM ( and ).

(a)

(b)

(c)

(d)

MDA is the product of lipid peroxidation of polyunsaturated fatty acids and the most popular indicator to determine oxidative stress. Therefore, we measured the MDA level of yeast after treatment with 1 at 24 h interval. As shown in Figure 5(b), the MDA levels of yeast at 24 h decreased significantly after treatment with 1 at 1, 3, and 10 μM (). These results suggested that antioxidative stress had an important role in the antiaging potential of 1.

Catalase (CAT) and glutathione peroxidase (GPx) take important roles in antioxidative stress. To understand whether these two enzymes involved in antiaging effect of 1 as SOD, we measured the enzyme activity of CAT and GPx, respectively. The significant increase activity of these two enzymes was observed in the 1-treated groups compared with the control group (Figures 5(c) and 5(d), and ). These results suggested that CAT and GPx took part in antioxidative stress during treatment with 1 prolonging the lifespan of yeast.

3.6. Effect of 1 on the Gene Expression of Sir2, Uth1, and TORC1 in Yeast

Sir2, Uth1, and TORC1 genes involve in the regulation of the aging process. To understand whether these genes take important roles in antiaging of 1, we checked the gene expression with RT-PCR and showed them in Figure 6. After treatment of 1 at 1 and 3 μM, the gene expression of Sir2 in yeast significantly increased (). Meanwhile, the Uth1 gene expression of yeast significantly decreased ( and ). However, significant changes of TORC1 gene expression of yeast were not observed. These results suggested that only Sir2 and Uth1 genes involved in antiaging effect of 1.

3.7. Effects of 1 on the Lifespan of sod1, sod2, uth1, and skn7 Mutants with a K6001 Background

The Sod gene is involved in free radical scavenging activity. Uth1 is an aging gene, and Skn7 is the transcriptional activator of UTH1. To understand whether these genes are involved in the antiaging effect of 1, we performed replicative lifespan assay by using sod1, sod2, uth1, and skn7 mutants with a K6001 background to check the effect of 1. As shown in Figures 7(a)–7(d), the lifespan of sod1 and sod2 mutants was shorter than that of K6001. The lifespan of uth1 mutant was longer than that of K6001, and it was consistent with other reports [11–13]. 1 did not show any effect on the lifespan of mutants. These results suggested that Sod, Uth1 and Skn7 had important roles in the antiaging effect of 1.

(a)

(b)

(c)

(d)

Figure 7

Effect of 1 on the replicative lifespan of sod1 (a), sod2 (b), uth1 (c), and skn7 (d) mutants with a K6001 background. The average lifespan of K6001 in the control group was , resveratrol at 10 μM was , and 1 at 3 μM was . (a) The average lifespan of Δsod1 in the control group was and 1 at 3 μM was . (b) The average lifespan of Δsod2 in the control group was and 1 at 3 μM was . (c) The average lifespan of Δuth1 in the control group was and 1 at 3 μM was . (d) The average lifespan of Δskn7 in the control group was and 1 at 3 μM was . indicates a significant difference relative to the corresponding control ().

4. Discussion

G. elata, a traditional Chinese medicine, is widely used for the treatment of age-related pathologies [15]. Gastrodin, a phenolic glycoside, is the main bioactive constituent of G. elata. It exhibits neuroprotective effect in various age-related disorders by modulating neurotransmitters, exerting antioxidative and anti-inflammatory properties, suppressing microglial activation, regulating mitochondrial cascades, and upregulating neurotrophins [27, 28]. To better understand the antiaging potential of G. elata, it is essential to identify more active ingredients and their underlying mechanisms. In our previous study, we reported parishin as an antiaging compound from G. elata by using the replicative lifespan assay of K6001 yeast. Parishin significantly extended the lifespan of yeast via antioxidative stress, increased the Sir2 gene expression, and inhibited the Uth1/TOR signaling pathway [13]. In the present study, we used the same method lifespan assay to isolate a new antiaging compound from G. elata and confirmed its antiaging effect with the chronological lifespan of YOM36 again. Results of lifespan assay in Figure 3 indicated that this compound not only extended the replicative lifespan but also the chronological lifespan of yeast, and the antiaging effect of 1 was stronger than that of resveratrol. The antiaging effect of 1 was comparable to our other compounds [11–13]. The structure of the new compound was characterized by extensive spectroscopic analysis, including 1D and 2D NMR, HR-ESI-TOF-MS, and chemical derivatization. Thus, the structure of the new compound in Figures 1 and 2 was elucidated as bis(4-hydroxybenzyl)ether mono-β-L-galactopyranoside (1).

The mitochondrion is an organelle that supplies a large amount of energy using an electron transport chain and oxidative phosphorylation and contributes to cellular activities. However, this process also generates reactive oxygen species (ROS) which causes oxidative damage to mitochondrial lipids, DNA, and proteins [5, 6]. Oxidative stress is considered as a major environmental factor in aging [29]. In our previous study, we found that parishin, one of the compounds from G. elata, produced antiaging effect via regulation of the Sir2/Uth1/TOR signaling pathway and antioxidative stress [13]. To indicate whether these two compounds have the same mechanism of action, we performed antioxidative stress, ROS and MDA assays. The results in Figures 4 and 5 suggested that antioxidation played an important role in the antiaging effect of 1. Moreover, we detected the change of catalase and total glutathione peroxidase activity. The significant increase of enzyme activity in Figures 5(c) and 5(d) clarified that 1 produced antioxidative stress via increase of catalase and glutathione peroxidase activity.

The oxidant and antioxidant system takes important roles for antioxidative stress. Sod gene is one of the antioxidative stress genes that participate in free radical scavenging [30]. Uth1 is a gene of oxidative stress, and inactivation of Uth1 increased resistance to oxidants [31]. It is regulated by Skn7 which is the transcriptional activator of UTH1 [32]. Sir2 belonged to longevity genes; Sir2 and TOR signaling pathways were involved in regulating the process of aging [33–35]. To check whether these genes are related to antiaging effect of 1, we detected the gene expression of them with RT-PCR. At the same time, we used the lifespan assay on sod1, sod2, uth1, and skn7 mutants to confirm the effects of 1 on these signaling pathways. Results in Figures 6 and 7 indicated that Sir2, Sod, Uth1 and Skn7 genes involved in the antiaging effect of 1. Interestingly, the gene expression of TORC1 was not affected by 1 like parishin.

Because K6001 and YOM36 yeast strains are mutants, we wanted to understand whether the compounds screened from nature products have antiaging effect on normal cells. Hence, in addition to lifespan analysis, we tried to use wild-type yeast BY4741 for mechanism analysis. Since chemical reductants are well known to reduce toxic effects of oxidants such as hydrogen peroxide by simple chemistry, it is possible that 1 could have acted directly as a free radical scavenger to clear the oxidants such as hydrogen peroxide and MDA. At this point, we will need to indicate it in the future.

In the present study, we utilized the characteristic of K6001 that mother cells can live in galactose and glucose medium but daughter cells will die in glucose medium to do replicative lifespan assay. We did the lifespan assay on glucose agar plates and accurately knew the daughter cell numbers produced by one mother cell. This method compared with the standard replicative lifespan assay was easy to operate, greatly shortened the assay time, and increased the high-throughput screen of samples. However, the dead daughter cells on the agar plate were observed under a microscope, and forty mother cells were randomly selected. Therefore, the results of lifespan assay were affected by artificial factors. Recently, other research team improved the replicative lifespan assay of K6001 yeast and measured it via the change of OD₆₀₀ in liquid glucose medium culture after administrating samples [36]. In spite of that, this method was more accurate and had a higher throughput screen but it did not know the produced generations of mother cells. Moreover, this method did not show replicative lifespan extension in many strains containing gene deletion known to extend the lifespan. Therefore, this method is not suitable to do high-throughput screening for small molecule that prolongs the replicative lifespan.

5. Conclusion

A new antiaging compound was isolated from G. elata that extended the lifespan of yeast. The structure of the compound was elucidated as bis(4-hydroxybenzyl)ether mono-β-L-galactopyranoside. Mechanism studies revealed that the antiaging potential of compound (1) depended on its antioxidative ability including the reduction of the ROS and MDA level and increase of CAT and GPx activity in yeast and regulation of the genes of Sod1, Sod2, Sir2, Uth1 and Skn7. This might be a valuable lead compound for drug discovery against age-related pathologies, and G. elata is worthy of further investigation to obtain more antiaging lead compounds.

Data Availability

All the figures and table used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare no financial or commercial conflict of interest.

Authors’ Contributions

Umer Farooq and Yanjun Pan contributed equally to this study.

Acknowledgments

The authors are grateful to Akira Matsuura (Chiba University, Japan) for the gifts of BY4741 and all mutations with the K6001 background and grateful to Michael Breitenbach (Salzburg University, Austria) for the gifts of K6001. This work was financially supported by the National Key R&D Program of China (No. 2017YFE0117200) and NSFC (Grant nos. 21661140001, 21877098, and 21572204).

References

T. Niccoli and L. Partridge, “Ageing as a risk factor for disease,” Current Biology, vol. 22, no. 17, pp. R741–R752, 2012.
View at: Publisher Site | Google Scholar
C. López-Otín, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, “The hallmarks of aging,” Cell, vol. 153, no. 6, pp. 1194–1217, 2013.
View at: Publisher Site | Google Scholar
A. Aliper, L. Jellen, F. Cortese et al., “Towards natural mimetics of metformin and rapamycin,” Aging, vol. 9, no. 11, pp. 2245–2268, 2017.
View at: Publisher Site | Google Scholar
A. Vaiserman and O. Lushchak, “Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives,” Journal of Translational Medicine, vol. 15, no. 1, article 160, p. 160, 2017.
View at: Publisher Site | Google Scholar
H. Cui, Y. Kong, and H. Zhang, “Oxidative stress, mitochondrial dysfunction, and aging,” Journal of Signal Transduction, vol. 2012, Article ID 646354, 13 pages, 2012.
View at: Publisher Site | Google Scholar
G. Z. Réus, A. S. Carlessi, R. H. Silva, L. B. Ceretta, and J. Quevedo, “Relationship of oxidative stress as a link between diabetes mellitus and major depressive disorder,” Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 8637970, 6 pages, 2019.
View at: Publisher Site | Google Scholar
R. G. Cutler, “Antioxidants and aging,” The American Journal of Clinical Nutrition, vol. 53, no. 1, pp. 373S–379S, 1991.
View at: Publisher Site | Google Scholar
I. Sadowska-Bartosz and G. Bartosz, “Effect of antioxidants supplementation on aging and longevity,” BioMed Research International, vol. 2014, Article ID 404680, 17 pages, 2014.
View at: Publisher Site | Google Scholar
B. M. Wasko and M. Kaeberlein, “Yeast replicative aging: a paradigm for defining conserved longevity interventions,” FEMS Yeast Research, vol. 14, no. 1, pp. 148–159, 2014.
View at: Publisher Site | Google Scholar
C. He, C. Zhou, and B. K. Kennedy, “The yeast replicative aging model,” Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, vol. 1864, no. 9, pp. 2690–2696, 2018.
View at: Publisher Site | Google Scholar
X. Cao, Y. Sun, Y. Lin et al., “Antiaging of Cucurbitane Glycosides from Fruits of Momordica charantia L,” Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 1538632, 10 pages, 2018.
View at: Publisher Site | Google Scholar
Y. Weng, L. Xiang, A. Matsuura, Y. Zhang, Q. Huang, and J. Qi, “Ganodermasides A and B, two novel anti-aging ergosterols from spores of a medicinal mushroom Ganoderma lucidum on yeast via UTH1 gene,” Bioorganic & Medicinal Chemistry, vol. 18, no. 3, pp. 999–1002, 2010.
View at: Publisher Site | Google Scholar
Y. Lin, Y. Sun, Y. Weng, A. Matsuura, L. Xiang, and J. Qi, “Parishin from Gastrodia elata extends the lifespan of yeast via regulation of Sir2/Uth1/TOR signaling pathway,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4074690, 11 pages, 2016.
View at: Publisher Site | Google Scholar
S. Jarolim, J. Millen, G. Heeren, P. Laun, D. Goldfarb, and M. Breitenbach, “A novel assay for replicative lifespan in Saccharomyces cerevisiae,” FEMS Yeast Research, vol. 5, no. 2, pp. 169–177, 2004.
View at: Publisher Site | Google Scholar
H. D. Zhan, H. Y. Zhou, Y. P. Sui et al., “The rhizome of Gastrodia elata Blume–an ethnopharmacological review,” Journal of Ethnopharmacology, vol. 189, pp. 361–385, 2016.
View at: Publisher Site | Google Scholar
N. Li, K. J. Wang, J. J. Chen, and J. Zhou, “Phenolic compounds from the rhizomes of Gastrodia elata,” Journal of Asian Natural Products Research, vol. 9, no. 4, pp. 373–377, 2007.
View at: Publisher Site | Google Scholar
T. Y. Jung, S. I. Suh, H. Lee et al., “Protective effects of several components of Gastrodia elata on lipid peroxidation in gerbil brain homogenates,” Phytotherapy Research, vol. 21, no. 10, pp. 960–964, 2007.
View at: Publisher Site | Google Scholar
J. Y. Lee, Y. W. Jang, H. S. Kang, H. Moon, S. S. Sim, and C. J. Kim, “Anti-inflammatory action of phenolic compounds from Gastrodia elata root,” Archives of Pharmacal Research, vol. 29, no. 10, pp. 849–858, 2006.
View at: Publisher Site | Google Scholar
H. Kumar, I. S. Kim, S. V. More, B. W. Kim, Y. Y. Bahk, and D. K. Choi, “Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson’s disease model,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 514095, 13 pages, 2013.
View at: Publisher Site | Google Scholar
Y. W. Jang, J. Y. Lee, and C. J. Kim, “Anti-asthmatic activity of phenolic compounds from the roots of Gastrodia elata Bl,” International Immunopharmacology, vol. 10, no. 2, pp. 147–154, 2010.
View at: Publisher Site | Google Scholar
F. Qiu, T. T. Liu, Z. W. Qu, C. Y. Qiu, Z. Yang, and W. P. Hu, “Gastrodin inhibits the activity of acid-sensing ion channels in rat primary sensory neurons,” European Journal of Pharmacology, vol. 731, pp. 50–57, 2014.
View at: Publisher Site | Google Scholar
T. Tanaka, T. Nakashima, T. Ueda, K. Tomii, and I. Kouno, “Facile discrimination of aldose enantiomers by reversed-phase HPLC,” Chemical & Pharmaceutical Bulletin, vol. 55, no. 6, pp. 899–901, 2007.
View at: Publisher Site | Google Scholar
F. Berrué, M. W. B. McCulloch, P. Boland et al., “Isolation of steroidal glycosides from the Caribbean sponge Pandaros acanthifolium,” Journal of Natural Products, vol. 75, no. 12, pp. 2094–2100, 2012.
View at: Publisher Site | Google Scholar
Y. Maruyama, T. Ito, H. Kodama, and A. Matsuura, “Availability of amino acids extends chronological lifespan by suppressing hyper-acidification of the environment in Saccharomyces cerevisiae,” PLOS One, vol. 11, no. 3, article e0151894, 2016.
View at: Publisher Site | Google Scholar
I. Liguori, G. Russo, F. Curcio et al., “Oxidative stress, aging, and diseases,” Clinical Interventions in Aging, vol. 13, pp. 757–772, 2018.
View at: Publisher Site | Google Scholar
D. Harman, “The free radical theory of aging: effect of age on serum copper levels,” Journal of Gerontology, vol. 20, no. 2, pp. 151–153, 1965.
View at: Publisher Site | Google Scholar
Y. Liu, J. Gao, M. Peng et al., “A review on central nervous system effects of gastrodin,” Frontiers in Pharmacology, vol. 9, article 24, 2018.
View at: Publisher Site | Google Scholar
S. C. C. Chik, T. C. T. Or, D. Luo, C. L. H. Yang, and A. S. Y. Lau, “Pharmacological effects of active compounds on neurodegenerative disease with gastrodia and uncaria decoction, a commonly used poststroke decoction,” The Scientific World Journal, vol. 2013, Article ID 896873, 22 pages, 2013.
View at: Publisher Site | Google Scholar
G. S. B. Aseervatham, T. Sivasudha, R. Jeyadevi, and D. Arul Ananth, “Environmental factors and unhealthy lifestyle influence oxidative stress in humans—an overview,” Environmental Science and Pollution Research, vol. 20, no. 7, pp. 4356–4369, 2013.
View at: Publisher Site | Google Scholar
Y. Wang, R. Branicky, A. Noë, and S. Hekimi, “Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling,” The Journal of Cell Biology, vol. 217, no. 6, pp. 1915–1928, 2018.
View at: Publisher Site | Google Scholar
N. Camougrand, I. Kiššová, G. Velours, and S. Manon, “Uth1p: a yeast mitochondrial protein at the crossroads of stress, degradation and cell death,” FEMS Yeast Research, vol. 5, no. 2, pp. 133–140, 2004.
View at: Publisher Site | Google Scholar
L. C. Lai, A. L. Kosorukoff, P. V. Burke, and K. E. Kwast, “Metabolic-state-dependent remodeling of the transcriptome in response to anoxia and subsequent reoxygenation in Saccharomyces cerevisiae,” Eukaryotic Cell, vol. 5, no. 9, pp. 1468–1489, 2006.
View at: Publisher Site | Google Scholar
K. T. Howitz, K. J. Bitterman, H. Y. Cohen et al., “Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan,” Nature, vol. 425, no. 6954, pp. 191–196, 2003.
View at: Publisher Site | Google Scholar
C. W. Ha and W. K. Huh, “The implication of Sir2 in replicative aging and senescence in Saccharomyces cerevisiae,” Aging, vol. 3, no. 3, pp. 319–324, 2011.
View at: Publisher Site | Google Scholar
S. Wullschleger, R. Loewith, and M. N. Hall, “TOR signaling in growth and metabolism,” Cell, vol. 124, no. 3, pp. 471–484, 2006.
View at: Publisher Site | Google Scholar
G. Tombline, J. I. Millen, B. Polevoda et al., “Effects of an unusual poison identify a lifespan role for Topoisomerase 2 in Saccharomyces cerevisiae,” Aging, vol. 9, no. 1, pp. 68–97, 2016.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Umer Farooq et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1299

Downloads

1086

Citations